Clinical Trials Logo

Clinical Trial Summary

Study the change of retrofoveolar choroidal thickness measured by optical coherence tomography during aerobic exercise inducing an increase in systolic blood pressure in healthy subjects.Ten healthy participants will perform an exercise (riding a bicycle ergometer) and will be examined with EDI-OCT. Each participant will be scanned before exercise, during the exercise and afterwards at 0 and 5 min. Each OCT measurement will be coupled to the arterial blood pressure evaluation.


Clinical Trial Description

Currently there is a growing interest in the study of the choroid in the pathogenesis of many ocular pathologies such as central serous chorioretinitis1, age-related macular degeneration, diabetic retinopathy, and myopia. Moreover, the recent development of new imaging methods allows the exploration of the normal and pathological processes of the choroid. In particular, the Enhanced Depth Imaging (EDI) mode in Optical Coherence Tomography (OCT) provides cross-sectional imaging of the choroid and in vivo measurement of its thickness. Understanding the factors that would modify the choroidal thickness would make it possible to better understand the pathophysiology of many chorioretinal pathologies and would help to guide therapeutics in the future.

However, systemic changes induced by physical activity, and in particular changes in systolic blood pressure, could be responsible for changes in the choroidal blood flow and thus in the choroidal thickness. The study consists in testing ten patients who will perform an exercise testing as part of the practice of a sportive activity. Patients will undergo an OCT in EDI mode to measure the retrofoveolar choroidal thickness during the exercise.

Each OCT image will be coupled to the evaluation of blood pression and heart rate.

Patients are treated in the usual way but the study is an interventional study, with minimal risks and constraints, because of the imaging (OCT image in EDI mode). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03532867
Study type Interventional
Source University Hospital, Toulouse
Contact Vincent SOLER, MD
Phone 5 61 77 71 74
Email soler.v@chu-toulouse.fr
Status Not yet recruiting
Phase N/A
Start date July 2019
Completion date July 2020

See also
  Status Clinical Trial Phase
Completed NCT04075188 - Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid N/A
Completed NCT03144596 - The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil Phase 4
Completed NCT03321253 - Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification N/A
Not yet recruiting NCT06272851 - Measuring Choroidal Thickness Using Optical Coherence Tomography
Completed NCT03811366 - Multimodal Analysis and Electroretinogram in VKH From Acute Onset - Part I N/A
Recruiting NCT05623293 - Ophthalmologic Outcomes in Patients With Carotid Artery Stenosis
Completed NCT05225597 - The Effect of Intracameral Carbachol and Epinephrine on Choroidal Thickness N/A
Not yet recruiting NCT04255524 - Choroidal Change on OCTA in Eyes With High Myopia N/A